Hospitals, including those participating in the 340B Drug Pricing Program, are the true safety-net, not the pharmaceutical industry with its “skyrocketing prescription drug prices and huge profits,” AHA Executive Vice President Tom Nickels writes in an AHASTAT blog post today. Nickels notes that hospitals care for all patients regardless of their ability to pay, and they have provided more than $500 billion in uncompensated care since 2000. He also highlights that hospitals participating in the 340B program use savings from the program to “provide free or reduced-priced prescription drugs to poorer residents” and “reinvest in programs that enhance patient services and access to care.” Nickels also cites various reports detailing the rapid spike in the costs of prescription drugs, including a Centers for Medicare & Medicaid Services report showing that prescription drug spending increased 12.6% in 2014. For more on the 340B program, visit www.aha.org/protect340B.

Related News Articles

Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…
Blog
Public
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4…
Headline
The Centers for Medicare & Medicaid Services Dec. 15 published the Measures Under Consideration List for 2025. These are measures that CMS is considering…
Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District…